PATENT CLAIM ANALYSIS

Application Number: 15910913
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "499000"]

Abstract:
In one embodiment, the present application discloses synthetic LDL nanoparticles comprising mixtures of components selected from the group consisting of phospholipids, triglycerides, cholesterol ester and free cholesterol; optionally further comprising an agent selected from the group consisting of natural antioxidants, ubiquinol and vitamin E, and methods for preparing the synthetic nanoparticles. The disclosed synthetic LDL nanoparticles are capable of selectively delivering lipophilic drugs and prodrugs to cellular targets expressing LDL receptors after intra venous injection.

Claim (Index 26):
The method of  claim 23 , wherein the cholesterol ester is selected from the group consisting of C 16-22  esters of cholesterol and mixtures thereof; and the triglycerides is selected from the group consisting of soybean oil, triolein, glyceryl tripalmitate and mixtures thereof.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 1.45614
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14485713', '15243659', '15675399', '13489247', '15131318']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7781543260747817
- 35 USC 102 Novelty (BERT): 0.6393934500970514
- Combined Prediction Score: 0.7642782384770087
- Mean Citation Score: 427.13168
- Max Citation Score: 614.1732
- Similarity Product: 556.9006482607841

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test